Recombinant Human CD40 Ligand/TNFSF5 Protein, >95% (SDS-PAGE&HPLC), high purity

Features and benefits
  • Expression System: E.coli
  • Accession #: P29965
  • Protein Tag: No tag
  • Bioactivity: Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 5-10 ng/ml.
  • Endotoxin Concentration: <1.0 EU/μg
Item Number
rp152636
Grouped product items
SKUSizeAvailabilityPrice Qty
rp152636-10μg
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$59.90
rp152636-50μg
50μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$139.90
rp152636-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$229.90
rp152636-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,989.90

Animal Free, >95% (SDS-PAGE&HPLC), Active, E.coli, No tag,113-263 aa

Basic Description

Product NameRecombinant Human CD40 Ligand/TNFSF5 Protein, >95% (SDS-PAGE&HPLC), high purity
SynonymsCD154 antigen; CD154; CD40 antigen ligand; CD40 Ligand; CD40L; CD40-L; CD40LG; CD40LIGM; gp39; hCD40L; HIGM1; T-B cell-activating molecule; T-BAM; T-cell antigen Gp39; TNF-related activation protein; TNFSF5; TNFSF5IMD3; TRAP; TRAPtumor necrosis factor (li
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free
Product Description

Purity
>95% (SDS-PAGE&HPLC)
Endotoxin level
<1.0 EU/μg
Function
Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL-4. Involved in immunoglobulin class switching. Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and an matrix metalloproteinases (MMP) inhibitor-sensitive pathway.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, ≥95%(SDS-PAGE&HPLC)
Purity>95% (SDS-PAGE&HPLC)
BioactivityFully biologically active when compared to standard. The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 5-10 ng/ml.
Endotoxin Concentration<1.0 EU/μg
Expression SystemE.coli
SpeciesHuman
Amino Acids113-263 aa
SequenceMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLWLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL
Protein TagNo tag
Accession #P29965
Predicted molecular weight16.3 kDa
SDS-PAGE16.3 kDa

Images

Recombinant Human CD40 Ligand/TNFSF5 Protein (rp152636) - Protein Bioactivity
Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 5-10 ng/mL.

Recombinant Human CD40 Ligand/TNFSF5 Protein (rp152636) - SDS-PAGE
Recombinant Human CD40 Ligand/TNFSF5 Protein was resolved with SDS-PAGE under reducing (R) and visualized by Coomassie® Blue staining. Showing a single band at 16.3 kDa.

Product Specifications

FormLyophilized
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-0.3 mg/mL. Stock solutions should be apportio
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And Storage12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. Upon delivery aliquot. Avoid freeze/thaw cycle.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F1001351Certificate of AnalysisOct 19, 2023 rp152636
ZJ23F1001352Certificate of AnalysisOct 19, 2023 rp152636
ZJ23F1001353Certificate of AnalysisOct 19, 2023 rp152636

Related Documents

References

1. Chen J, Song Y, Bojadzic D, Tamayo-Garcia A, Landin AM, Blomberg BB, Buchwald P..  (2017)  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction..  J Med Chem,  60  (21): (8906-8922).  [PMID:29024591]
2. Xiao HY,Li N,Duan JJ,Jiang B,Lu Z,Ngu K,Tino J,Kopcho LM,Lu H,Chen J,Tebben AJ,Sheriff S,Chang CY,Yanchunas J,Calambur D,Gao M,Shuster DJ,Susulic V,Xie JH,Guarino VR,Wu DR,Gregor KR,Goldstine CB,Hynes J,Macor JE,Salter-Cid L,Burke JR,Shaw PJ,Dhar TGM.  (2020)  Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches..  J Med Chem,  63  (23): (15050-15071).  [PMID:33261314]
3. Graf, D D, Korthäuer, U U, Mages, H W HW, Senger, G G and Kroczek, R A RA..  (1992)  Cloning of TRAP, a ligand for CD40 on human T cells..  European journal of immunology,      [PMID:1280226]
4. Spriggs, M K MK and 7 more authors..  (1992)  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion..  The Journal of experimental medicine,    (1):   [PMID:1281209]
5. Hollenbaugh, D D and 8 more authors..  (1992)  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity..  The EMBO journal,      [PMID:1385114]
6. Saiki, O O and 9 more authors..  (1995)  Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM..  The Journal of clinical investigation,      [PMID:7532185]
7. Gauchat, J F JF and 6 more authors..  (1993)  Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production..  FEBS letters,    (11):   [PMID:7678552]
8. Aruffo, A A and 9 more authors..  (1993)  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome..  Cell,    (29):   [PMID:7678782]
9. Korthäuer, U U and 9 more authors..  (1993)  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM..  Nature,    (11):   [PMID:7679206]
10. Allen, R C RC and 9 more authors..  (1993)  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome..  Science (New York, N.Y.),    (12):   [PMID:7679801]
11. Macchi, P P and 9 more authors..  (1995)  Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry..  American journal of human genetics,      [PMID:7717401]
12. Shimadzu, M M and 6 more authors..  (1995)  Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome..  Biochimica et biophysica acta,    (2):   [PMID:7999797]
13. DiSanto, J P JP, Bonnefoy, J Y JY, Gauchat, J F JF, Fischer, A A and de Saint Basile, G G..  (1993)  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM..  Nature,    (11):   [PMID:8094231]
14. Lin, Q Q and 9 more authors..  (1996)  A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome..  The Journal of clinical investigation,    (1):   [PMID:8550833]
15. Karpusas, M M and 6 more authors..  (1995)  2 A crystal structure of an extracellular fragment of human CD40 ligand..  Structure (London, England : 1993),    (15):   [PMID:8589998]
16. Blotta, M H MH, Marshall, J D JD, DeKruyff, R H RH and Umetsu, D T DT..  (1996)  Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:8617933]
17. Pietravalle, F F and 7 more authors..  (1996)  Human native soluble CD40L is a biologically active trimer, processed inside microsomes..  The Journal of biological chemistry,    (15):   [PMID:8626375]
18. Katz, F F and 5 more authors..  (1996)  Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome..  Human mutation,      [PMID:8889581]
19. Nonoyama, S S and 7 more authors..  (1997)  Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome..  Human genetics,      [PMID:9150729]
20. Singh, J J and 7 more authors..  (1998)  The role of polar interactions in the molecular recognition of CD40L with its receptor CD40..  Protein science : a publication of the Protein Society,      [PMID:9605317]
21. Seyama, K K and 6 more authors..  (1998)  Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome..  Blood,    (1):   [PMID:9746782]
22. Khandekar, S S SS and 9 more authors..  (2001)  Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells..  Protein expression and purification,      [PMID:11676606]
23. Mikolajczak, Sebastian A SA and 5 more authors..  (2004)  The modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells..  The Journal of experimental medicine,    (5):   [PMID:15067037]
24. Ouadani, Hanen H and 14 more authors..  (2016)  Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients..  Immunogenetics,      [PMID:26545377]
25. Takada, Yoko K; Yu, Jessica; Shimoda, Michiko and Takada, Yoshikazu..  (2019)  Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling..  Journal of immunology (Baltimore, Md. : 1950),    (1):   [PMID:31331973]

Solution Calculators